Analyst Articles – US

Phillips 66 Partners (PSXP) Downgraded to Neutral at Bank of America

Bank of America cut shares of Phillips 66 Partners (NYSE:PSXP) from a buy rating to a neutral rating in a research note issued to investors on Monday, Marketbeat Ratings reports. Several other equities analysts also recently commented on PSXP. Morgan Stanley downgraded Phillips 66 Partners from an equal weight rating to an underweight rating and […]

Axsome Therapeutics (AXSM) PT Set at $16.00 by Cantor Fitzgerald

Cantor Fitzgerald set a $16.00 price objective on Axsome Therapeutics (NASDAQ:AXSM) in a research report released on Monday morning. The brokerage currently has a buy rating on the stock. Other equities analysts also recently issued research reports about the stock. HC Wainwright reaffirmed a buy rating and set a $10.00 price target on shares of […]

Red Hat (RHT) Earns “Buy” Rating from Monness Crespi & Hardt

Monness Crespi & Hardt reissued their buy rating on shares of Red Hat (NYSE:RHT) in a research note issued to investors on Monday, MarketBeat reports. They currently have a $190.00 price target on the open-source software company’s stock, up from their prior price target of $186.00. Several other equities analysts also recently commented on RHT. […]

BMO Capital Markets Reiterates “Hold” Rating for United Natural Foods (UNFI)

BMO Capital Markets reaffirmed their hold rating on shares of United Natural Foods (NASDAQ:UNFI) in a research note published on Monday morning, The Fly reports. They currently have a $14.00 price objective on the stock. The analysts noted that the move was a valuation call. UNFI has been the topic of a number of other […]

Williams Capital Analysts Give Cimarex Energy (XEC) a $109.00 Price Target

Cimarex Energy (NYSE:XEC) has been given a $109.00 target price by analysts at Williams Capital in a report issued on Wednesday. The brokerage presently has a “buy” rating on the oil and gas producer’s stock. Williams Capital’s price objective would indicate a potential upside of 52.49% from the stock’s previous close. XEC has been the […]

ValuEngine Lowers Vitamin Shoppe (VSI) to Buy

ValuEngine cut shares of Vitamin Shoppe (NYSE:VSI) from a strong-buy rating to a buy rating in a research report released on Tuesday morning. Several other brokerages also recently issued reports on VSI. Zacks Investment Research downgraded Vitamin Shoppe from a strong-buy rating to a hold rating in a research report on Saturday, September 22nd. Morgan […]

Wells Fargo & Co (WFC) Downgraded by ValuEngine to Sell

Wells Fargo & Co (NYSE:WFC) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday. Other equities research analysts have also recently issued research reports about the stock. Citigroup raised shares of Wells Fargo & Co from a “neutral” rating to a […]

Domtar (UFS) Downgraded to Strong Sell at ValuEngine

ValuEngine cut shares of Domtar (NYSE:UFS) (TSE:UFS) from a sell rating to a strong sell rating in a report published on Tuesday morning. Several other equities analysts also recently commented on UFS. BMO Capital Markets upped their price objective on shares of Domtar from $47.00 to $52.00 and gave the company a market perform rating […]

Grupo Aeroportuario dl Srst SAB CV (ASR) Raised to Neutral at Citigroup

Citigroup upgraded shares of Grupo Aeroportuario dl Srst SAB CV (NYSE:ASR) from a sell rating to a neutral rating in a research report report published on Tuesday morning, Marketbeat.com reports. A number of other brokerages also recently issued reports on ASR. ValuEngine raised Grupo Aeroportuario dl Srst SAB CV from a strong sell rating to […]

Arlo Technologies (ARLO) Upgraded to Hold by Zacks Investment Research

Arlo Technologies (NYSE:ARLO) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday. According to Zacks, “Arlo Technologies, Inc. product design, wireless connectivity, cloud infrastructure and cutting-edge AI capabilities focuses on delivering a seamless, smart home experience. The company’s cloud-based platform provides users with visibility, […]

Adecoagro (AGRO) Cut to “Hold” at Santander

Santander downgraded shares of Adecoagro (NYSE:AGRO) from a buy rating to a hold rating in a research note released on Tuesday, The Fly reports. Other equities research analysts have also recently issued reports about the company. ValuEngine upgraded Adecoagro from a strong sell rating to a sell rating in a research note on Tuesday, October […]

Aluminum Corp. of China Limited ADR Class H (ACH) Rating Lowered to Neutral at Goldman Sachs Group

Aluminum Corp. of China Limited ADR Class H (NYSE:ACH) was downgraded by Goldman Sachs Group from a “buy” rating to a “neutral” rating in a report released on Wednesday, Marketbeat reports. ACH has been the subject of a number of other research reports. ValuEngine raised shares of Aluminum Corp. of China Limited ADR Class H […]

Ironwood Pharmaceuticals (IRWD) Given a $12.00 Price Target by HC Wainwright Analysts

HC Wainwright set a $12.00 target price on Ironwood Pharmaceuticals (NASDAQ:IRWD) in a report published on Monday morning, The Fly reports. The firm currently has a sell rating on the biotechnology company’s stock. IRWD has been the subject of several other reports. BidaskClub downgraded Ironwood Pharmaceuticals from a hold rating to a sell rating in […]

Big Lots (BIG) Price Target Cut to $44.00 by Analysts at KeyCorp

Big Lots (NYSE:BIG) had its price target cut by KeyCorp from $53.00 to $44.00 in a research report sent to investors on Monday, The Fly reports. They currently have an overweight rating on the stock. KeyCorp also issued estimates for Big Lots’ Q4 2019 earnings at $2.30 EPS, FY2019 earnings at $3.67 EPS and FY2020 […]

Bank of America Lowers Shell Midstream Partners (SHLX) to Underperform

Bank of America cut shares of Shell Midstream Partners (NYSE:SHLX) from a neutral rating to an underperform rating in a research note issued to investors on Monday, MarketBeat.com reports. SHLX has been the subject of several other research reports. Zacks Investment Research cut shares of Shell Midstream Partners from a buy rating to a hold […]

Coherus Biosciences (CHRS) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Coherus Biosciences (NASDAQ:CHRS) from a sell rating to a hold rating in a research note published on Monday. According to Zacks, “Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of […]

Credit Suisse Group Reaffirms Buy Rating for Adobe (ADBE)

Credit Suisse Group reaffirmed their buy rating on shares of Adobe (NASDAQ:ADBE) in a research report released on Monday. They currently have a $300.00 target price on the software company’s stock. Other research analysts have also recently issued research reports about the stock. Jefferies Financial Group boosted their price objective on shares of Adobe to […]

Magna International (MGA) Research Coverage Started at KeyCorp

KeyCorp initiated coverage on shares of Magna International (NYSE:MGA) (TSE:MG) in a research note released on Monday morning, Marketbeat.com reports. The brokerage issued a sector weight rating on the stock. KeyCorp also issued estimates for Magna International’s Q4 2018 earnings at $1.67 EPS, Q1 2019 earnings at $1.77 EPS, Q2 2019 earnings at $1.82 EPS, […]

argenx (ARGX) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of argenx (NASDAQ:ARGX) from a buy rating to a hold rating in a research report report published on Monday. According to Zacks, “argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company’s product pipeline consists of ARGX-113, ARGX-110 […]

HC Wainwright Reiterates “$36.00” Price Target for Celcuity (CELC)

HC Wainwright set a $36.00 price target on Celcuity (NASDAQ:CELC) in a research note issued to investors on Monday. The firm currently has a buy rating on the stock. “Our price target is derived from a market value of the firm at $369M, which includes a discounted cash flow based asset value for CELx tests, […]

Zscaler (ZS) Research Coverage Started at Guggenheim

Guggenheim initiated coverage on shares of Zscaler (NASDAQ:ZS) in a report published on Monday, Marketbeat.com reports. The brokerage issued a neutral rating and a $40.00 price target on the stock. ZS has been the subject of a number of other reports. Needham & Company LLC upped their price objective on shares of Zscaler from $45.00 […]

Secureworks (SCWX) Rating Lowered to Equal Weight at Morgan Stanley

Morgan Stanley cut shares of Secureworks (NASDAQ:SCWX) from an overweight rating to an equal weight rating in a research report sent to investors on Monday morning, MarketBeat reports. They currently have $17.00 price objective on the technology company’s stock. Other analysts also recently issued research reports about the stock. First Analysis downgraded shares of Secureworks […]

BTIG Research Begins Coverage on Solid Biosciences (SLDB)

BTIG Research initiated coverage on shares of Solid Biosciences (NASDAQ:SLDB) in a research note published on Monday morning, Marketbeat Ratings reports. The brokerage issued a neutral rating on the stock. A number of other research firms have also weighed in on SLDB. Credit Suisse Group assumed coverage on shares of Solid Biosciences in a research […]

Royal Bank of Canada (RY) Upgraded to Buy at TD Securities

TD Securities upgraded shares of Royal Bank of Canada (NYSE:RY) (TSE:RY) from a hold rating to a buy rating in a report published on Monday, MarketBeat.com reports. A number of other research analysts have also recently commented on the company. Scotiabank upgraded Royal Bank of Canada from a sector perform rating to an outperform rating […]

Odonate Therapeutics (ODT) Upgraded by Zacks Investment Research to Hold

Odonate Therapeutics (NASDAQ:ODT) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Friday. According to Zacks, “Odonate Therapeutics, LLC is a pharmaceutical company. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company focused […]